NCT03932292View on ClinicalTrials.gov

Ectoin® Mouth Wash (EML03) in the Prevention and Treatment of Radiation-induced Oral Mucositis

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

October 30, 2019

Study Completion Date

November 5, 2019

Conditions
Oral Mucositis Due to Radiation
Interventions
DRUG

Ectoin Mouth Wash

According to medical prescription of the instruction for use under consideration (at least 4x1 ampoule (5ml) daily, rinsed in the mouth for at least 30 seconds)

DRUG

Supersaturated solution of calcium and phosphate ions

According to medical prescription of the instruction for use under consideration (4 times a day).

Trial Locations (1)

1122

Department of Radiotherapy, National Institute of Oncology, Budapest

All Listed Sponsors
lead

Bitop AG

INDUSTRY

NCT03932292 - Ectoin® Mouth Wash (EML03) in the Prevention and Treatment of Radiation-induced Oral Mucositis | Biotech Hunter | Biotech Hunter